Related Experiment Video
Updated: May 1, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
The role of academic medical centers in advancing regulatory science
1Virginia Center for Translational and Regulatory Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Abstract:
The US Food and Drug Administration (FDA) has oversight of an increasingly complex array of therapeutic and scientific advances, as well as an expanded mission that now includes enabling innovation. This complex mission necessitates access to and understanding of relevant scientific expertise in what is commonly called “regulatory science.” Academic medical centers have much of this relevant expertise, and there is an increasing need and opportunity for the FDA to engage with them to shape the regulatory science agenda.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Global Regulatory Systems
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

